Life Extension Clinical Research, Inc. conducted a study investigating the effectiveness of 90 days of PEAK ATP® oral supplementation. Specifically, the study examined blood glucose levels, blood flow, body composition and general health in elderly male and female subjects (55.4±6.4 years). NutraIngredients USA reported on the findings which were presented by Life Extension Researchers at Experimental Biology 2017. Click here to read the full article.

TSI Group Named Finalist for Marketing Initiative of the Year
TSI Group, developer and exclusive global supplier of clinically proven ingredients myHMB® and PEAK ATP®, has been named a finalist in the 2025 NutraIngredients-Asia Awards

